跳至主要内容
临床试验/RBR-2md5dr
RBR-2md5dr进行中(未招募)未知

Determination of the prognostic value of the expression profile of micro RNAs in patients with Chagas disease

Hospital São Rafael0 个研究点开始时间: 2015年4月14日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18Y 至 70Y(—)

入选标准

  • Chagas disease confirmed by 2 different serological tests; optimized drug therapy; NYHA functional class II-III-IV or patients with the indeterminate form; patients of any gender and aged 18 to 70 years.

排除标准

  • Valvulopathy with hemodynamic consequences; chronic use of immunosuppressive agents; renal failure on current treatment by dialysis; acute infections or systemic infections in accordance with the definition of sepsis ACCP/SCCM (American College of Chest Phisicians/Society of Critical Care Medicine); abuse alcohol or illicit drugs (Based on DSM IV), any comorbidity with impact on survival in two years; liver, pulmonary, hematologic, neoplastic, bone, inflammatory or infectious diseases.

研究者

发起方
Hospital São Rafael

相似试验